AbbVie Must Detail Efforts To Kneecap Humira Biosimilars
AbbVie Inc. has thrown "wrenches into the gears" of high-stakes patent litigation over its hugely popular immunosuppressant Humira, a Delaware magistrate judge said Friday, ordering the drugmaker to swiftly detail any...To view the full article, register now.
Already a subscriber? Click here to view full article